Steroid excretion in users of the injectable combined oestrogen progestogen preparation, deladroxate

LYNESTRENOL 1 mg.-mestranol 0.1 mg. a new low dose oral contraceptive. a clinical study

Blood coagulation and fibrinolysis with an injectable long-acting progestogen-oestrogen contraceptive

Effect of the combined steroidal contraceptives Gynanovlar 21& Lyndiol 2.5 on the human adrenocortical and ovarian activities

Profile of women with an unmet need for family planning from a child survival perspective

Menstrual blood loss during oral contraceptive therapy and in I.U.D. users

Histopathological and histochemical changes in the cervix uteri under contraceptive

LIVER FUNCTION STUDIES WITH AN OESTROGEN-PROGESTOGEN INJECTABLE CONTRACEPTIVE

Natural Fertility and Associated Intermediate Variables in Some Arab Countries

EXPERIENCE WITH A NEW LOW DOSE ORAL CONTRACEPTIVE